{
    "2020-08-26": [
        [
            {
                "time": "",
                "original_text": "九洲药业（603456）：业绩符合预期 CDMO板块高速增长 股权激励为公司保驾护航",
                "features": {
                    "keywords": [
                        "九洲药业",
                        "业绩",
                        "CDMO",
                        "高速增长",
                        "股权激励"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金动向盘点：反手加仓茅台，但“食药”持仓占比已达31.3%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "茅台",
                        "食药",
                        "持仓占比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}